Medicine
Nithiodote kit
Nithiodote kit is a prescription medicine containing Sodium nitrite and Sodium thiosulfate, marketed by Hope Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store at controlled room temperature between 20°C and 25°C…
Key facts
- Active ingredient (INN)
- Sodium nitrite and Sodium thiosulfate
- Brand
- Nithiodote
- Dosage form
- Kit
- Packs
- 1 kit
- Marketing authorisation holder
- Hope Pharmaceuticals
- Manufacturer
- Hope Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store at controlled room temperature between 20°C and 25°C (68°F - 77°F), excursions permitted to 15-30°C (59 to 86°F). Protect from direct light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 January 2011
- Identifiers
- RxCUI 237832, 253010, 1086835 +1DailyMed set ID ff4941b3-9901-4aab-adcf-c5327bede34eNDC 60267-812Application NDA201444
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton * 10 mL in 1 vial, single-use * 50 mL in 1 vial, single-dose | 60267-812-00 | Hope Pharmaceuticals | 14 January 2011 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 14 January 2011 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Sodium nitrite and Sodium thiosulfate is a fixed-dose combination medicine indicated for the treatment of acute cyanide poisoning that is judged to be serious or life-threatening. It is available as kits. MedsAcross supplies Sodium nitrite and Sodium thiosulfate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Sodium nitrite and Sodium thiosulfateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- NITHIODOTE prescribing information (Hope Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Nithiodote kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.